Adverse Events Following Immunisation
Surveillance of adverse events following immunisation (AEFI) aims to monitor vaccine and immunisation program safety and to detect population-specific, rare, late-onset or unexpected adverse events that may not be detected in pre-licensure vaccine trials. An Australia-wide annual report for 2007 on AEFI surveillance has been published (Communicable Diseases Intelligence 2008; 32: 371-387)
